학술논문

Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population
Document Type
Article
Source
In: Oncologist. (Oncologist, February 2024, 29(2):E266-E274)
Subject
Language
English
ISSN
1549490X
10837159